154 related articles for article (PubMed ID: 10492139)
1. Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?
Allgayer H; Böhne P; Kruis W
Dig Dis Sci; 1999 Aug; 44(8):1600. PubMed ID: 10492139
[No Abstract] [Full Text] [Related]
2. [Mesalazine-induced acute hepatitis].
Domínguez Jiménez JL; Pelado García EM; Copado Herrera R
Gastroenterol Hepatol; 2015 Apr; 38(4):302-3. PubMed ID: 25458543
[No Abstract] [Full Text] [Related]
3. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.
Borum ML; Ginsberg AL
Dig Dis Sci; 1999 Jul; 44(7):1494. PubMed ID: 10489937
[No Abstract] [Full Text] [Related]
4. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.
Bakowski MT; Prescott P
Dig Dis Sci; 2002 Feb; 47(2):469. PubMed ID: 11855570
[No Abstract] [Full Text] [Related]
5. Adult fibrosing colonopathy associated with mesalazine treatment.
Gaia E; Sambatoro A; De Giuli P; Angeli A
Am J Gastroenterol; 2001 Aug; 96(8):2508-9. PubMed ID: 11513205
[No Abstract] [Full Text] [Related]
6. Hypersensitivity to 5-ASA suppositories.
Weidenhiller M; Raithel M; Hahn EG
Dig Dis Sci; 1999 Dec; 44(12):2552-3. PubMed ID: 10630512
[No Abstract] [Full Text] [Related]
7. Hypersensitivity to 5-ASA suppositories.
Borum ML; Ginsberg A
Dig Dis Sci; 1997 May; 42(5):1076-8. PubMed ID: 9149065
[No Abstract] [Full Text] [Related]
8. Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?
Yönal O; Hatemi G; Kaymakoğlu S
Turk J Gastroenterol; 2012; 23 Suppl 2():21-4. PubMed ID: 23576086
[No Abstract] [Full Text] [Related]
9. [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].
Kim KH; Kim TN; Jang BI
Korean J Gastroenterol; 2007 Dec; 50(6):379-83. PubMed ID: 18159175
[TBL] [Abstract][Full Text] [Related]
10. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
Gionchetti P; Rizzello F; Venturi A; Brignola C; Ferretti M; Peruzzo S; Campieri M
Aliment Pharmacol Ther; 1997 Dec; 11(6):1053-7. PubMed ID: 9663829
[TBL] [Abstract][Full Text] [Related]
12. Mesalazine-induced interstitial nephritis.
Skalova S; Dedek P; Pozler O; Podhola M
Ren Fail; 2009; 31(2):159-61. PubMed ID: 19212915
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
Cohen HD; Das KM
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
[TBL] [Abstract][Full Text] [Related]
14. Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.
Richter JM; Arshi NK; Oster G
Can J Gastroenterol Hepatol; 2016; 2016():6928710. PubMed ID: 27446860
[TBL] [Abstract][Full Text] [Related]
15. What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
Riley SA
Gut; 1998 Jun; 42(6):761-3. PubMed ID: 9691909
[No Abstract] [Full Text] [Related]
16. Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.
Prieto G; Pérez-Moneo B; Molina M; Ramos E; Sarría J; Larrauri J; Tovar JA
Inflamm Bowel Dis; 2009 Oct; 15(10):1452-3. PubMed ID: 19097230
[No Abstract] [Full Text] [Related]
17. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
[No Abstract] [Full Text] [Related]
18. [Intestinal mucosa as the focal point. In distal ulcerative colitis relief with topical therapy].
MMW Fortschr Med; 2004 Jun; 146(23):62-3. PubMed ID: 15373138
[No Abstract] [Full Text] [Related]
19. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
Kao J; Kwok K; Das KM
J Clin Gastroenterol; 2010 Sep; 44(8):531-5. PubMed ID: 20495466
[TBL] [Abstract][Full Text] [Related]
20. Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.
Kohli R; Melin-Aldana H; Sentongo TA
J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):479-82. PubMed ID: 16205520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
